LILIA ACEBRON: Open Payments
NPI 1063946556 · SEFFNER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 12 payments from 8 companies in 2025. Trend: 2023 $893 · 2024 $643 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $225 |
| Exact Sciences Corporation | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: FARXIGA, Cologuard Collection Kit, SHINGRIX, PREVNAR 20, IBSRELA, QULIPTA, Wegovy, REXULTI.
Industry payments across FL — which companies pay providers there.
